Cargando…

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae

BACKGROUND: Bloodstream infections (BSIs) by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (Kp) are associated with high mortality. The aim of this study is to assess the relationship between time to administration of appropriate antibiotic therapy and the outcome of pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falcone, Marco, Bassetti, Matteo, Tiseo, Giusy, Giordano, Cesira, Nencini, Elia, Russo, Alessandro, Graziano, Elena, Tagliaferri, Enrico, Leonildi, Alessandro, Barnini, Simona, Farcomeni, Alessio, Menichetti, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993311/ https://www.ncbi.nlm.nih.gov/pubmed/32000834 http://dx.doi.org/10.1186/s13054-020-2742-9

Ejemplares similares

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae–Producing KPC-31, a D179Y Variant of KPC-3
por: Tiseo, Giusy, et al.
Publicado: (2021)

Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020
por: Falcone, Marco, et al.
Publicado: (2020)

Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization
por: Tiseo, Giusy, et al.
Publicado: (2023)

Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak
por: Falcone, Marco, et al.
Publicado: (2020)

Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy
por: Falcone, Marco, et al.
Publicado: (2020)

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
por: Russo, Alessandro, et al.
Publicado: (2020)

Reduced Fitness Costs of mcr-1.2 Compared to Mutated pmrB in Isogenic Colistin-Resistant KPC-3-Producing Klebsiella pneumoniae
por: Giordano, Cesira, et al.
Publicado: (2019)

Predictors and outcomes of respiratory bacterial coinfections in patients with COVID‐19 admitted to hospital: An observational prospective study
por: Tiseo, Giusy, et al.
Publicado: (2022)

Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study
por: Tumbarello, Mario, et al.
Publicado: (2022)

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification
por: Falcone, Marco, et al.
Publicado: (2021)

Management of COVID patients with convalescent plasma: Do we have the final word?
por: Menichetti, Francesco, et al.
Publicado: (2022)

Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality
por: Corcione, Silvia, et al.
Publicado: (2022)

Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes: Results From a Prospective Cohort Study
por: Falcone, Marco, et al.
Publicado: (2016)

Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla(KPC), virulence factors and their impacts on clinical outcome
por: Xu, Min, et al.
Publicado: (2018)

Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
por: Falcone, Marco, et al.
Publicado: (2020)

Transmission of KPC producing Klebsiella pneumoniae despite appropriate barrier precautions of an intensive care unit in the Netherlands
por: Diederen, B, et al.
Publicado: (2011)

Bloodstream Infections caused by Klebsiella pneumoniae and Serratia marcescens isolates co-harboring NDM-1 and KPC-2
por: Bes, Taniela, et al.
Publicado: (2021)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Prompt and Appropriate Antimicrobial Therapy Improves Outcomes of NDM-Producing and KPC-Producing Klebsiella pneumoniae Bloodstream Infections in Patients Hospitalized for COVID-19: A Comparative Retrospective Case-Series
por: Bavaro, Davide Fiore, et al.
Publicado: (2022)

Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy
por: Brescini, Lucia, et al.
Publicado: (2019)

Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score–Adjusted Analysis
por: Falcone, Marco, et al.
Publicado: (2019)

Molecular epidemiology of KPC-producing Klebsiella pneumoniae clinical isolates in hospitals in North-Western Tuscany
por: Buzzigoli, A, et al.
Publicado: (2011)

Emergence of KPC-producing Klebsiella pneumoniae in Italy
por: Fontana, Carla, et al.
Publicado: (2010)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant bla(KPC-2)-Producing Klebsiella pneumoniae Carrying bla(VEB-25)
por: Zarras, Charalampos, et al.
Publicado: (2023)

A Prospective Evaluation of Two Rapid Phenotypical Antimicrobial Susceptibility Technologies for the Diagnostic Stewardship of Sepsis
por: Giordano, Cesira, et al.
Publicado: (2018)

How to manage KPC infections
por: Bassetti, Matteo, et al.
Publicado: (2020)

170. Outcomes after Stenotrophomonas maltophilia bloodstream infection
por: Al-Jabri, Maha Y, et al.
Publicado: (2023)

Management of infections due to KPC-producing Klebsiella pneumoniae
por: Deresinski, Stanley C, et al.
Publicado: (2009)

KPC-producing Klebsiella pneumoniae, finally targeting Turkey
por: Labarca, J, et al.
Publicado: (2014)

Skin and soft tissue infections in the elderly
por: Falcone, Marco, et al.
Publicado: (2023)

Prevalence of bla(KPC-2), bla(KPC-3) and bla(KPC-30)—Carrying Plasmids in Klebsiella pneumoniae Isolated in a Brazilian Hospital
por: Migliorini, Letícia B., et al.
Publicado: (2021)

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Co-Harboring blaKPC-Carrying Plasmid and pLVPK-Like Virulence Plasmid in Bloodstream Infections
por: Du, Fang-ling, et al.
Publicado: (2021)

The Modified Hodge Test: Is it an appropriate method for detection of KPC enzyme or not?
por: Kalantar-Neyestanaki, Davood, et al.
Publicado: (2015)

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity
por: Yoon, Eun-Jeong, et al.
Publicado: (2020)

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
por: Chen, Luke F, et al.
Publicado: (2012)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

First detection of KPC-3-producing Klebsiella pneumoniae in Albania
por: Kostyanev, T., et al.
Publicado: (2015)

The role of the bla(KPC) gene in antimicrobial resistance of Klebsiella pneumoniae
por: Ghasemnejad, Atossa, et al.
Publicado: (2019)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
por: Huang, Yanqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6l8hh3a70mmfuq34oqg9350tgm